Northwest Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Buy |
1,716
+9
| +0.5% | +$1.67K | 0.06% | 145 |
|
|
2025
Q1 | $358K | Buy |
1,707
+2
| +0.1% | +$419 | 0.07% | 121 |
|
|
2024
Q4 | $303K | Buy |
1,705
+7
| +0.4% | +$1.24K | 0.06% | 123 |
|
|
2024
Q3 | $335K | Buy |
1,698
+8
| +0.5% | +$1.58K | 0.08% | 114 |
|
|
2024
Q2 | $290K | Buy |
1,690
+22
| +1% | +$3.77K | 0.08% | 122 |
|
|
2024
Q1 | $304K | Sell |
1,668
-229
| -12% | -$41.7K | 0.08% | 124 |
|
|
2023
Q4 | $294K | Sell |
1,897
-54
| -3% | -$8.37K | 0.09% | 122 |
|
|
2023
Q3 | $291K | Sell |
1,951
-339
| -15% | -$50.5K | 0.1% | 120 |
|
|
2023
Q2 | $309K | Buy |
2,290
+33
| +1% | +$4.45K | 0.11% | 112 |
|
|
2023
Q1 | $360K | Sell |
2,257
-5
| -0.2% | -$797 | 0.14% | 104 |
|
|
2022
Q4 | $366K | Buy |
2,262
+158
| +8% | +$25.5K | 0.16% | 100 |
|
|
2022
Q3 | $282K | Sell |
2,104
-312
| -13% | -$41.8K | 0.12% | 115 |
|
|
2022
Q2 | $370K | Buy |
2,416
+606
| +33% | +$92.8K | 0.16% | 104 |
|
|
2022
Q1 | $293K | Buy |
+1,810
| New | +$293K | 0.14% | 108 |
|
|
2021
Q3 | – | Sell |
-3,167
| Closed | -$357K | – | 116 |
|
|
2021
Q2 | $357K | Buy |
+3,167
| New | +$357K | 0.19% | 92 |
|
|
2019
Q2 | – | Sell |
-813
| Closed | -$65K | – | 118 |
|
|
2019
Q1 | $65K | Buy |
813
+100
| +14% | +$8K | 0.05% | 196 |
|
|
2018
Q4 | $66K | Hold |
713
| – | – | 0.06% | 179 |
|
|
2018
Q3 | $67K | Hold |
713
| – | – | 0.05% | 191 |
|
|
2018
Q2 | $66K | Hold |
713
| – | – | 0.05% | 195 |
|
|
2018
Q1 | $68K | Buy |
+713
| New | +$68K | 0.05% | 189 |
|